| Q2 2024 |
202 |
$316M |
+$117M |
-$143M |
-$25.5M |
HES, ACI, CPRI, AMED, CCIX
|
13F-HR |
8/14/2024, 10:03 AM |
| Q1 2024 |
214 |
$341M |
+$154M |
-$109M |
+$45.7M |
SCRM, PXD, AMED, ACI, TRTL
|
13F-HR |
5/13/2024, 11:31 AM |
| Q4 2023 |
197 |
$294M |
+$142M |
-$123M |
+$19.1M |
AMED, RPT, LCAA, CVII, SRC
|
13F-HR |
2/13/2024, 06:58 PM |
| Q3 2023 |
277 |
$320M |
+$180M |
-$118M |
+$61.4M |
ATVI, SPY, HZNP, SPY, SPLK
|
13F-HR |
11/13/2023, 06:58 PM |
| Q2 2023 |
261 |
$261M |
+$216M |
-$78.3M |
+$138M |
ATVI, ATVI, SPY, SGEN, HZNP
|
13F-HR |
8/14/2023, 04:41 PM |
| Q1 2023 |
175 |
$123M |
+$96.9M |
-$8.15M |
+$88.8M |
KVSC, IXAQ, APEN, HZNP, CIIG
|
13F-HR |
5/12/2023, 06:07 PM |
| Q4 2022 |
121 |
$115M |
|
|
|
STOR, EVOP, COWN, MYOV, VMW
|
13F-HR |
2/13/2023, 05:19 PM |